Skg Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SKG PHARMA, and what generic and branded alternatives to SKG PHARMA drugs are available?
SKG PHARMA has three approved drugs.
Drugs and US Patents for Skg Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Skg Pharma | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | CAPSULE;ORAL | 218202-002 | Apr 10, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Skg Pharma | CABERGOLINE | cabergoline | TABLET;ORAL | 218618-001 | Jun 26, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Skg Pharma | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 218163-001 | Apr 9, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Skg Pharma | NICARDIPINE HYDROCHLORIDE | nicardipine hydrochloride | CAPSULE;ORAL | 218202-001 | Apr 10, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.